Pieter Imhof appointed chief executive officer BioBTX B.V.

Pieter Imhof appointed chief executive officer BioBTX B.V.
augustus 15, 2017 BioBTX

BioBTX B.V. has announced that starting 15 September 2017 Mr. Pieter Imhof has been appointed Chief Executive Officer (CEO) of BioBTX BV. In this role Mr Imhof will especially focus on the further upscaling and commercialization of the BioBTX technology.

On behalf of the shareholders, Cor Kamminga explains: “With the appointment of Pieter Imhof, we strengthen both the technical and commercial nature of BioBTX B.V., which will give us greater appeal to industrial partners to realize our growth strategy. Pieter brings a lot of  experience in both the chemical and the energy sector and has a lot of experience in shaping strategic partnerships. “

Pieter Imhof (Netherlands, 1962) has held various management positions over a 16 years period at AkzoNobel Catalysts (later Albemarle Catalysts) in R&D, product & market development as well as Technical Service. In these roles he has successfully developed and commercialized several catalysts, catalysts components and additives worldwide.

After Albemarle Mr. Imhof has been responsible for business development and strategic account management in the Catalysis contract research and systems business unit of Avantium Chemicals BV, in the period in which Avantium grew from startup to a leading chemical technology company. Mr. Imhof holds a Ph.D. degree in chemistry after studies in chemistry,  business economics and strategy.

0 Reacties

Laat een reactie achter

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

*